Acts on desire, not blood flow
PT-141 (bremelanotide) activates melanocortin receptors in the brain, which are involved in sexual desire and arousal.
Compounded in the U.S.A.Rx onlyDesire, needle-free.
Used as needed.
Compounded in the U.S.A.
Used as needed.No needles.
Illustrative image — not a CAPO Health patientIllustrative image; actual packaging may vary.
Compounded · peptide nasal spray · for women and men
The same peptide as the injection, in a nasal spray you use as needed — no needles.
From $129/month
Description
PT-141 (bremelanotide) is a peptide that activates melanocortin receptors in the brain, which are involved in sexual desire and arousal.
Unlike PDE5 inhibitors, it does not act on blood flow. Any use your provider prescribes it for may be off-label, and individual results vary.
Plans & pricing
Your plan
$129/month
15 mL
Choose your plan
No subscription required · cancel anytime from your account · no cancellation fee.
Choose PT-141 Nasal Spray · monthly plan → Questions? Call 1-833-772-7117No enrollment, consultation or membership fees. If treatment isn't right for you, you're refunded in full.
Prescription only. Important Safety Information
PT-141 (bremelanotide) activates melanocortin receptors in the brain, which are involved in sexual desire and arousal.
Unlike PDE5 inhibitors such as sildenafil and tadalafil, it does not act on blood flow. Any use your provider prescribes it for may be off-label.
A nasal spray used as needed before sexual activity, only as your provider directs. For women and men.
Provider consultation, medication and supplies, shipping and your patient portal — in every plan.
A licensed provider reviews your short intake and follows up through your portal. No separate consultation fee.
Nasal spray dispensed by our partner pharmacy, as your provider directs.
Shipped to your door by our partner pharmacy, with tracking sent by email.
No separate enrollment, consultation or membership fees. Your plan price is the price.
Messages with your care team, refill requests and order tracking, HIPAA-secure.
If the provider decides treatment is not appropriate, nothing is dispensed and your order is refunded in full.
Features and services are subject to availability and eligibility. Portal preview is illustrative.
Start my online visit →Potential benefits
PT-141 (bremelanotide) is a peptide that acts on melanocortin receptors involved in sexual desire. It is prescribed for women and men, if a licensed provider decides it is appropriate for you. It may help support:
Support for sexual desire that has felt low.
Feeling more interested in closeness with your partner.
Taken before anticipated intimacy, not every day.
Individual results vary. Benefits are not guaranteed and depend on your provider's evaluation and your plan. Compounded PT-141 is not FDA-approved.
Why it matters
Many adults go through a drop in sexual desire, and for some it causes real distress. It's a recognized medical concern, not something you have to push through alone.
These signs have many possible causes. A licensed provider reviews your online form before recommending PT-141 or another option.
What does it do
From first question to follow-up
Complete a short online form about your goals and the medicines you take — it takes a few minutes — then check out.
A provider licensed in your state reviews your form and decides whether treatment is appropriate. If it is not, your order is refunded in full.
If prescribed, your medication is dispensed by our partner pharmacy and shipped to you. Check-ins continue through your patient portal.
Pharmacy & compliance
If a provider prescribes treatment, your medication is prepared by a state-licensed compounding pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act, and shipped to your door.
Our partner pharmacy is The Pharmacy Hub (Miami, FL). CAPO Health is not a pharmacy and does not compound, manufacture or dispense medications. Availability of certain medications or formulations can vary by state.
Illustrative image
Before you begin
A little clarity goes a long way.
No. Compounded PT-141 is prepared by a state-licensed 503A pharmacy for an individual patient under a provider's prescription. The FDA does not review or approve compounded drugs for safety, effectiveness or quality. Any use your provider prescribes it for may be off-label.
People with high blood pressure that is not controlled or with known heart disease, and anyone who is allergic to bremelanotide. Tell your provider about every medicine you take.
Nausea is very common, especially with the first doses. Flushing, headache, nasal irritation and vomiting can also occur. Read the Important Safety Information on this page before starting.
No. Insurance is not required. Your price is shown in your online visit, before checkout, and your provider confirms the details after reviewing your file.
If the licensed provider decides that treatment is not appropriate for you, you are notified with the reason and no medication is dispensed. Any amount you have already paid is refunded in full to your original payment method. Not everyone qualifies, and the provider may recommend a different path.
Compounded PT-141 is not approved by the FDA, and the FDA does not review it for safety, effectiveness or quality. Nausea is very common; flushing, headache and nasal irritation can occur.
PT-141 can briefly raise blood pressure and lower heart rate after each dose. It is not for people with uncontrolled high blood pressure or known heart disease.
Repeated use can darken areas of the skin and gums. It can slow digestion and affect some oral medicines. Read the full safety information below.
The online visit takes just a few minutes. If a licensed provider decides treatment isn't right for you, nothing is dispensed and you're refunded in full.
Questions? Call us at 1-833-772-7117
Important Safety Information
Compounded PT-141 (bremelanotide) is prepared by a state-licensed pharmacy for an individual patient. It is not approved by the FDA, and the FDA does not review compounded drugs for safety, effectiveness or quality. Any use your provider prescribes it for may be off-label.
have high blood pressure that is not controlled, have known heart or blood vessel disease, or are allergic to bremelanotide or any ingredient in the preparation.
have or have had high blood pressure, heart disease or a stroke, liver or kidney problems, are pregnant or could become pregnant, or take naltrexone or other medicines taken by mouth (PT-141 can slow how quickly some oral medicines are absorbed).
As a nasal spray, only as your provider directs. Do not use more than one dose in 24 hours or more often than your provider allows.
A temporary rise in blood pressure and drop in heart rate after each dose, severe nausea or vomiting, and darkening of the skin, face, gums or breasts (focal hyperpigmentation), which may not go away. Stop and contact your provider if you become pregnant.
Nausea, flushing, headache, nasal irritation and vomiting.
Compounded PT-141 (Bremelanotide) Nasal Spray is compounded by a state-licensed pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act and is dispensed only with a patient-specific prescription issued after a medical evaluation. It is not approved by the FDA and is not a generic version of, or equivalent to, any branded medication. Your price is shown in your online visit, before checkout; if no prescription is issued, your order is refunded in full. This summary does not include everything you need to know — talk to your provider and read your pharmacy label. To report side effects, contact your provider or the FDA at 1-800-FDA-1088. Individual results vary.
The FDA does not review compounded medications for safety, effectiveness or quality, and treatment requires an individual evaluation and a prescription. CAPO Health is not a pharmacy: if prescribed, your medication is prepared by a state-licensed compounding pharmacy and your pharmacy label shows the concentration and directions prescribed for you.
CAPO Health is a technology platform. CAPO Health is not a pharmacy and does not practice medicine. Medical services are provided by independent, state-licensed healthcare providers who exercise their own clinical judgment. Prescription only if a licensed provider determines it is clinically appropriate. Not everyone qualifies, and no treatment, outcome or eligibility is guaranteed.
Most medications referenced on this site are compounded preparations prepared by U.S. pharmacies licensed in the state where they dispense. Compounded drugs are not approved by the FDA and are not evaluated by the FDA for safety, effectiveness or quality. They are not generic versions of, or equivalent to, any branded medication. Some medications, such as oral tablets, may be dispensed as commercially manufactured products; your pharmacy label shows what was dispensed. Clinical evidence for wellness uses of NAD+, Lipo-B and glutathione is limited.
GLP-1 receptor agonists carry risks, including but not limited to nausea, vomiting, diarrhea, constipation, pancreatitis, gallbladder disease and, in animal studies, thyroid C-cell tumors. Discuss your full medical history, including any personal or family history of medullary thyroid carcinoma or MEN 2, with your provider. Every other treatment carries its own risks: PDE5 inhibitors must never be combined with nitrates. Read the Important Safety Information on each treatment page. This website does not provide medical advice and is not a substitute for consultation with a qualified clinician. In an emergency, call 911.
Weight figures, timelines and projections shown anywhere on this page are illustrative and drawn from published clinical literature, not from CAPO Health patient outcomes. Individual results vary. Your provider confirms the plan after review; if no prescription is issued, any amount paid is refunded in full. Product-specific risks, contraindications and side effects are listed in the Important Safety Information for each medication, available from every treatment card and from the footer. This site collects no protected health information — intake happens inside the secure, HIPAA-compliant patient portal.
People pictured on this site are illustrative images, not CAPO Health patients. They do not describe anyone's treatment experience and do not depict the results of any medication. Individual results vary.